Pathways Contributing to Chemotherapy-Induced Myotoxicity Are Attenuated by EPAโ+โDHA in a Clinically Relevant Model of Colorectal Cancer.
<p><b>BACKGROUND</b></p><p>Skeletal muscle loss is a well-recognized consequence of cancer, and chemotherapy exacerbates myotoxicity through multiple mechanisms. Retaining muscle mass improves tumour response to therapies and tolerance to chemotherapy; hence, interventions to mitigate myotoxicity warrant investigations. This study aimed to investigate...
๐๏ธ 2025-11-17
๐ฐ Publication: Journal Of Cachexia Sarcopenia And Muscle
Read MorePathways Contributing to Chemotherapy-Induced Myotoxicity Are Attenuated by EPAโ+โDHA in a Clinically Relevant Model of Colorectal Cancer.